市場調查報告書

性保健的全球市場 - 各產品種類·男女·各流通管道·各地區:市場規模·佔有率·未來展望·機會分析 (2019∼2027年)

Sexual Health Market, by Product Type, by Gender, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 924585
出版日期 內容資訊 英文 167 Pages
商品交期: 2-3個工作天內
價格
性保健的全球市場 - 各產品種類·男女·各流通管道·各地區:市場規模·佔有率·未來展望·機會分析 (2019∼2027年) Sexual Health Market, by Product Type, by Gender, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2020年01月22日內容資訊: 英文 167 Pages
簡介

本報告提供全球「性保健」的相關產品的市場相關分析,提供產品概要,及市場基本結構及促進·阻礙因素,整體市場規模預測 (以金額為準,過去2年·今後9年份),各產品種類·男女·各流通管道·各地區的詳細趨勢,主要企業的簡介·業績·策略計劃等調查。

第1章 分析目的·前提條件

第2章 市場概要

  • 分析概要
    • 市場定義和範圍
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 影響力分析
  • 市場趨勢
  • 主要開發
  • 技術進步
  • 企業合併·收購 (M&A)
  • 法規方案
  • 波特的五力分析
  • PEST分析

第4章 全球性保健的市場:各產品種類

  • 簡介
    • 市場佔有率分析 (2018年,2027年)
    • 與前一年同期相比成長率 (2017∼2027年)
  • 勃起功能障礙 (ED) 治療藥
    • 簡介
    • 市場規模與其預測,與前一年同期相比成長率 (以金額為準,2016∼2027年)
  • 性別不協調 (GD) 治療藥
  • 性慾減退障礙 (HSDD) 治療藥
  • 早洩治療藥
  • 其他

第5章 全球性保健市場:男女

  • 簡介
  • 男性
  • 適合女性

第6章 全球性保健市場:各流通管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第7章 全球性保健市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 東南亞國協
    • 澳洲
    • 韓國
    • 其他
  • 中南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東
    • 波灣合作理事會 (GCC) 各國
    • 以色列
    • 其他
  • 非洲
    • 北非
    • 中部非洲
    • 非洲南部

第8章 競爭環境

  • 熱圖分析
  • 企業簡介
    • Teva Pharmaceutical Industries Ltd.
      • 企業概要
      • 技術組合
      • 財務實際成果
      • 近來的主要趨勢
      • 策略
    • Meda Pharmaceuticals, Inc.
    • Eli Lilly & Company
    • Bayer AG
    • Vivus, Inc.
    • Zydus Pharmaceuticals
    • IVFTECH APS
    • Merck & Co.
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd
    • Novartis International AG
    • Mylan Pharmaceuticals Inc.
    • AstraZeneca

第9章 附錄

目錄

Sexual health is an important part of a person's physical and mental health. Sexual health leads to the healthy sexual life without any sexual dysfunctions, and preventive measures to avoid sexually transmitted infections. The adult population largely suffers from one or more sexual disorders such as dyspareunia, erectile dysfunctions, hypoactive sexual desire disorder, premature (early) ejaculation, and others. According to National Center for Biotechnology Information 2016, sexual dysfunction is highly prevalent, and affects around 43% of women and 31% of men, globally. Currently, various treatment options such as medication, mechanical aids, sexual therapies, and others are available for treating such sexual dysfunctions and to improve sexual health of the person.

Market Dynamics

  • Increasing incidence and prevalence of sexual disorders is a major factor augmenting growth of the market. Some of the major factors which cause sexual dysfunction are aging population, stressful and unhealthy lifestyle, and other psychological parameters. According to a study published in the National Center for Biotechnology Information in April 2016, hypoactive sexual desire disorder (HSDD) is present in around 8.9% and 12.3% women in the age group of 18 - 44 years and 45 - 64 years, respectively.
  • Moreover, robust product development activities by major key players is engaged in the introduction of innovative and highly effective drug treatment for improving sexual health. For instance, in June 2019, AMAG Pharmaceuticals received the U.S. FDA approval for Vyleesi (bremelanotide) for treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Thus, increasing approvals by regulatory authorities are expected to drive the growth of the sexual health market.

Key features of the study:

  • This report provides in-depth analysis of the global sexual health market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2020-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles leading players in the global sexual health market based on the following parameters - company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc., Eli Lilly & Company, Bayer AG, Vivus, Inc., Zydus Pharmaceuticals, IVFTECH APS, Merck & Co., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis International AG, Mylan Pharmaceuticals Inc., and AstraZeneca
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
  • The global sexual health market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers in the sexual health market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Sexual Health Market, By Product Type:
  • Erectile Dysfunction Drugs
  • Gender Dysphoria Drugs
  • Hypoactive Sexual Desire Disorder Drugs
  • Premature Ejaculation Drugs
  • Others
  • Global Sexual Health Market, By Gender:
  • Male
  • Female
  • Global Sexual Health Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Sexual Health Market, By Region:
  • North America
    • By Product Type:
  • Erectile Dysfunction Drugs
  • Gender Dysphoria Drugs
  • Hypoactive Sexual Desire Disorder Drugs
  • Premature Ejaculation Drugs
  • Others
    • By Gender:
  • Male
  • Female
    • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
    • By Country:
  • U.S.
  • Canada
  • Europe
    • By Product Type:
  • Erectile Dysfunction Drugs
  • Gender Dysphoria Drugs
  • Hypoactive Sexual Desire Disorder Drugs
  • Premature Ejaculation Drugs
  • Others
    • By Gender:
  • Male
  • Female
    • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Product Type:
  • Erectile Dysfunction Drugs
  • Gender Dysphoria Drugs
  • Hypoactive Sexual Desire Disorder Drugs
  • Premature Ejaculation Drugs
  • Others
    • By Gender:
  • Male
  • Female
    • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • By Product Type:
  • Erectile Dysfunction Drugs
  • Gender Dysphoria Drugs
  • Hypoactive Sexual Desire Disorder Drugs
  • Premature Ejaculation Drugs
  • Others
    • By Gender:
  • Male
  • Female
    • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • By Product Type:
  • Erectile Dysfunction Drugs
  • Gender Dysphoria Drugs
  • Hypoactive Sexual Desire Disorder Drugs
  • Premature Ejaculation Drugs
  • Others
    • By Gender:
  • Male
  • Female
    • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Product Type:
  • Erectile Dysfunction Drugs
  • Gender Dysphoria Drugs
  • Hypoactive Sexual Desire Disorder Drugs
  • Premature Ejaculation Drugs
  • Others
    • By Gender:
  • Male
  • Female
    • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Meda Pharmaceuticals, Inc.
    • Eli Lilly & Company
    • Bayer AG
    • Vivus, Inc.
    • Zydus Pharmaceuticals
    • IVFTECH APS
    • Merck & Co.
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd
    • Novartis International AG
    • Mylan Pharmaceuticals Inc.
    • AstraZeneca

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description

1. Market Definition and Scope

  • Executive Summary

1. Market Snippet, By Product Type

2. Market Snippet, By Gender

3. Market Snippet, By Distribution Channel

4. Market Snippet, By Region

  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics

1. Drivers

2. Restraints

3. Market Opportunities

  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Sexual Health Market, By Product Type, 2016 - 2027, (US$ Million)

  • Introduction

1. Market Share Analysis, 2018 and 2027 (%)

2. Y-o-Y Growth Analysis, 2017 - 2027

3. Segment Trends

  • Erectile Dysfunction Drugs

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

  • Gender Dysphoria Drugs

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

  • Hypoactive Sexual Desire Disorder Drugs

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

  • Premature Ejaculation Drugs

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

  • Others

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

5. Global Sexual Health Market, By Gender, 2016 - 2027, (US$ Million)

  • Introduction

1. Market Share Analysis, 2018 and 2027 (%)

2. Y-o-Y Growth Analysis, 2017 - 2027

3. Segment Trends

  • Male

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

  • Female

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Sexual Health Market, By Distribution Channel, 2016 - 2027, (US$ Million)

  • Introduction

1. Market Share Analysis, 2018 and 2027 (%)

2. Y-o-Y Growth Analysis, 2017 - 2027

3. Segment Trends

  • Hospital Pharmacy

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

  • Retail Pharmacy

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

  • Online Pharmacy

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Sexual Health Market, By Region, 2016 - 2027, (US$ Million)

  • Introduction

1. Market Share Analysis, By Region, 2018 and 2027 (%)

2. Y-o-Y Growth Analysis, By Region, 2016 - 2027

3. Regional Trends

  • North America

1. Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)

2. Market Size and Forecast, By Gender, 2016 - 2027, (US$ Million)

3. Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)

4. Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)

    • U.S.
    • Canada
  • Europe

1. Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)

2. Market Size and Forecast, By Gender, 2016 - 2027, (US$ Million)

3. Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)

4. Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)

    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific

1. Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)

2. Market Size and Forecast, By Gender, 2016 - 2027, (US$ Million)

3. Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)

4. Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)

    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America

1. Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)

2. Market Size and Forecast, By Gender, 2016 - 2027, (US$ Million)

3. Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)

4. Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)

    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East

1. Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)

2. Market Size and Forecast, By Gender, 2016 - 2027, (US$ Million)

3. Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)

4. Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)

    • GCC
    • Israel
    • Rest of Middle East
  • Africa

1. Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)

2. Market Size and Forecast, By Gender, 2016 - 2027, (US$ Million)

3. Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)

4. Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)

    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles

1. Teva Pharmaceutical Industries Ltd.

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

2. Meda Pharmaceuticals, Inc.

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

3. Eli Lilly & Company

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

4. Bayer AG

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

5. Vivus, Inc.

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

6. Zydus Pharmaceuticals

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

7. IVFTECH APS

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

8. Merck & Co.

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

9. Pfizer Inc.

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Sun Pharmaceutical Industries Ltd

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

11. Novartis International AG

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

12. Mylan Pharmaceuticals Inc.

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

13. AstraZeneca

    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact